•Temozolomide, bevacizumab, CPT11 and sorafenib inhibited tumor growth in both V600E-mutantand V600E-non-mutant xenograft models.•MEK inhibition (cobimetinib) but not BRAF inhibition (vemurafenib) inhibited tumor growth. This evidence concerns the gene BRAF and neoplasm.